Histamine and Immune Biomarkers in CNS Disorders

<div><i>APOE</i>-related blood histamine levels in Alzheimer’s disease. Concentration of blood histamine in patients with Alzheimer’s disease (AD) according to their apolipoprotein-E (<i>APOE</i>) genotype.<i> APOE</i> distribution and frequencies:<i> APOE</i>-2/3: 4%;<i> APOE</i>-2/4: 2%;<i> APOE</i>-3/3: 49%;<i> APOE</i>-3/4: 35%;<i> APOE</i>-4/4: 9%.</div>

Mediators of Inflammation

fig4

Figure 4

Figure 4: Histamine and Immune Biomarkers in CNS Disorders 